This company has been marked as potentially delisted and may not be actively trading. NASDAQ:EYEG AB Corporate Bond ETF (EYEG) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisDividendHeadlinesHoldingsOwnershipShort InterestTrendsBuy This Stock About AB Corporate Bond ETF (NASDAQ:EYEG) 30 days 90 days 365 days Advanced Chart Get AB Corporate Bond ETF alerts:Sign Up Key Stats Today's Range$34.52▼$34.6350-Day Range$1.59▼$2.2552-Week Range$33.92▼$37.24Volume2,893 shsAverage Volume1,352 shsMarket Capitalization$26.89 millionAssets Under Management$26.82 millionDividend Yield5.86%Net Expense Ratio0.30%Aggregate RatingN/A ETF Overview EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA. Read More AB Corporate Bond ETF ExpensesTypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFsManagement Fee0.30%0.23%0.32%0.54%0.53%Other Expenses0.00%0.11%0.27%0.52%0.56%Total Expense0.30%0.25%0.40%0.73%0.73%Fee Waiver0.00%-0.14%-0.26%-0.50%-0.63%Net Expense0.30%0.23%0.35%0.63%0.60% Receive EYEG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EYEG ETF News HeadlinesGoldman Sachs Access High Yield Corporate Bond ETF declares monthly distribution of $0.2568November 4, 2024 | msn.comVanguard ESG U.S. Corporate Bond ETF declares monthly distribution of $0.2408November 1, 2024 | msn.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks. | American Alternative (Ad)What Economic Factors Influence Corporate Bond Yields?October 30, 2024 | investopedia.comBUFC AB Conservative Buffer ETFOctober 27, 2024 | seekingalpha.comHigh Yield Corporate Bonds In Emerging Markets Are Red HotOctober 22, 2024 | seekingalpha.comSee More Headlines EYEG ETF - Frequently Asked Questions How were AB Corporate Bond ETF's earnings last quarter? AB Corporate Bond ETF (NASDAQ:EYEG) announced its earnings results on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.42) by $0.07. When did AB Corporate Bond ETF IPO? AB Corporate Bond ETF (EYEG) raised $5 million in an initial public offering (IPO) on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO. Who are AB Corporate Bond ETF's major shareholders? AB Corporate Bond ETF's top institutional shareholders include Alliancebernstein L.P. (76.00%), Wealth Enhancement Advisory Services LLC (14.94%) and Jane Street Group LLC (0.87%). View institutional ownership trends. What other stocks do shareholders of AB Corporate Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Bausch Health Cos (BHC), MannKind (MNKD), Bristol Myers Squibb (BMY), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX) and Novavax (NVAX). Fund Details IssuerAllianceBernstein Fund NameAB Corporate Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:EYEG Inception Date12/13/2023 Fund ManagerTimothy Kurpis, Bernd Wuebben Webwww.eyegatepharma.com Phone(781) 788-8869Fund Focus Asset ClassFixed Income BenchmarkN/A CategoryCorporate FocusInvestment Grade Development LevelBlended Development RegionGlobal Number of Holdings470 Fund Statistics Assets Under Management$26.82 million Average Daily Volume$0.00 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorAllianceBernstein L.P. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest1,300 shs Miscellaneous Outstanding Shares750,000Beta0.16 Creation Unit50,000 Creation Fee$250.00 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Top 10 EYEG HoldingsUs 5yr Note (Cbt) Sep25 Xcbt 20250930Holding Weight: 8.11%Us Long Bond(Cbt) Sep25 Xcbt 20250919Holding Weight: 6.46%Ultra 10 Year US Treasury Note Future Sept 25Holding Weight: 4.26%Alliancebernstein Govt Stif Ssc Fund 64ba Agis 587Holding Weight: 1.59%Oaktree Strategic Credit Fund 6.19%Holding Weight: 0.58%Athene Holding Ltd 6.625%Holding Weight: 0.53%Belrose Funding Trust II 6.792%Holding Weight: 0.53%Centene Corp. 3%Holding Weight: 0.53%Cox Communications, Inc. 5.8%Holding Weight: 0.53%Ford Motor Company 5.291%Holding Weight: 0.53%Full Holdings Details This page (NASDAQ:EYEG) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AB Corporate Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AB Corporate Bond ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access